comparemela.com

Latest Breaking News On - Michael schneiders - Page 9 : comparemela.com

BRAIN Biotech AG H1 20/ 21 Results

DGAP-News: BRAIN Biotech AG / Key word(s): Half Year Results/Half Year Report28.05.2021 / 07:30 The issuer is solely responsible for the content of this announcement.Zwingenberg, Germany, May 28th, 2021BRAIN Biotech AG H1 '20/'21 Results CRISPR Associated Nuclease with large business potential New Pharma Compound PH.

BRAIN Biotech AG expands stake in successful enzyme producer Biocatalysts Ltd

BRAIN Biotech AG expands stake in successful enzyme producer Biocatalysts Ltd. DGAP-News: BRAIN Biotech AG / Key word(s): Investment 12.05.2021 / 16:30 Zwingenberg, Germany, May 12, 2021 BRAIN Biotech AG expands stake in successful enzyme producer Biocatalysts Ltd. BRAIN has acquired additional shares in Biocatalysts Ltd. Biocatalysts strong business trend Planned additional capacity expansion now targeted earlier BRAIN Biotech AG has expanded its shareholdings in the successful enzyme producer Biocatalysts Ltd., Wales, to 82.2% by the purchase of additional shares from minority shareholders. Due to the strong business performance at Biocatalysts Ltd. current production capacity will be fully utilised although only coming on stream in early 2021. The 2nd phase of expansion is planned to be accelerated as a result.

Investegate |BRAIN Biotech AG Announcements | BRAIN Biotech AG: Genome Editing Tool Developed by BRAIN

- Different commercialization models currently being explored BRAIN Biotech AG has successfully completed the first development phase for a novel genome editing CRISPR Cas system applying its advanced metagenomics sequencing and protein engineering capabilities. BRAIN s technology enabled by a novel and independent Non-CAS9-Nuclease will significantly speed up in-house developments and promises significant economic upside. Genome editing has lately become one of the most exciting technologies in biotechnology. It allows for the directed and precise insertion, deletion or modification in the genome of a living organism. The CRISPR-CAS system has provided a genetic tool with speed as well as simplicity that was previously unavailable to science.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.